Letter: Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials

QR Code

Letter: Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials

Bibliographic Details
Main Authors:	Delatycki, M., Gurrin, L., Ong, S., Ramm, G., Anderson, G., Olynyk, John, Allen, K., Nicoll, A., Powell, L.
Format:	Journal Article
Published:	Elsevier 2015
Online Access:	http://hdl.handle.net/20.500.11937/31615

Similar Items

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial
by: Ong, S., et al.
Published: (2017)

Non-Hfe iron overload: Is phlebotomy the answer?
by: Hazeldine, S., et al.
Published: (2013)

Detection of HFE Haemochromatosis in the clinic and community using standard erythrocyte tests
by: Adris, N., et al.
Published: (2018)

Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)
by: Ong, S., et al.
Published: (2015)

Iron-overload-related disease in HFE hereditary hemochromatosis
by: Allen, K., et al.
Published: (2008)

The Natural History of Serum Iron Indices for HFE C282Y Homozygosity Associated With Hereditary Hemochromatosis
by: Gurrin, L., et al.
Published: (2008)

A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis
by: Constantine, C., et al.
Published: (2009)

Haemochromatosis
by: Carroll, G., et al.
Published: (2013)

Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age
by: Shi, Z., et al.
Published: (2009)

HFE C282Tyr homozygotes with serum ferritin concentrations below 100ug/L are at low risk of hemochromatosis
by: Allen, K., et al.
Published: (2010)

HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
by: Osborne, N., et al.
Published: (2010)

Natural history and management of HFE hemochromatosis
by: Gan, E., et al.
Published: (2011)

Natural history of HFE simple heterozygosity for C282Y and H63D: A prospective 12-year study
by: Zaloumis, S., et al.
Published: (2015)

Hereditary hemochromatosis in the post-HFE era
by: Olynyk, John, et al.
Published: (2008)

Effects of HFE gene mutations and alcohol on iron status, liver biochemistry and morbidity
by: Olynyk, John, et al.
Published: (2011)

HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity
by: Gurrin, L., et al.
Published: (2009)

HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women
by: Warne, C., et al.
Published: (2017)

The Role of Hfe in Transferrin-Bound Iron Uptake by Hepatocytes
by: Chua, A., et al.
Published: (2008)

Genotype-Phenotype Relationship in Hereditary Haemochromatosis
by: Ayres, Lachlan, et al.
Published: (2013)

Infection control in Phlebotomy
by: Thandar Soe, Sumaiyah Jamaludin
Published: (2016)

Reply: Does the death knell toll for phlebotomy in NAFLD?
by: Adams, Leon, et al.
Published: (2015)

Brain transcriptome perturbations in the Hfe -/- mouse model of genetic iron loading
by: Johnstone, D., et al.
Published: (2012)

Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis.
by: Chua, A., et al.
Published: (2010)

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial
by: Adams, L., et al.
Published: (2015)

Noncitrus Fruits as Novel Dietary Environmental Modifiers of Iron Stores in People With or Without HFE Gene Mutations
by: Milward, E., et al.
Published: (2008)

Changes in gene expression of cholesterol metabolism pathways in mouse models of haemochromatosis
by: Graham, Ross, et al.
Published: (2013)

Iron and Hepatic Carcinogenesis
by: Tirnitz-Parker, Janina, et al.
Published: (2013)

Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis
by: Yeap, B., et al.
Published: (2015)

Therapeutic venesection at the Australian Red Cross Blood Service: Impact of the High Ferritin Application on management of hereditary haemochromatosis
by: Bentley, P., et al.
Published: (2015)

HFE gene polymorphisms in Malays
by: Jatta, Francis
Published: (2020)

Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis
by: Sherrington, C., et al.
Published: (2006)

Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study
by: Davis, T., et al.
Published: (2008)

Jugular venipuncture and other innovative approaches to phlebotomy among people who inject drugs
by: Ferguson, C., et al.
Published: (2015)

A comparison of self-reported and record-linked blood donation history in an Australian cohort
by: Bertalli, N., et al.
Published: (2011)

Tachypleus gigas mortality due biomedical bleeding process
by: John, Akbar, et al.
Published: (2011)

An analysis on phlebotomists in tertiary hospital regarding their perceived values toward phlebotomy certification / Nur Anisah Noor Habibullah
by: Noor Habibullah, Nur Anisah
Published: (2016)

Directions for clinical practice improvement in HFE gene mutation testing
by: Gillett, M., et al.
Published: (2007)

Diagnosing and preventing iron overload
by: Ramanathan, G., et al.
Published: (2017)

Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk
by: Johnstone, D., et al.
Published: (2012)

Response to letters regarding article, "television viewing time and mortality: The Australian diabetes, obesity and lifestyle study (AusDiab)"
by: Dunstan, D., et al.
Published: (2010)